Debora holds a degree in Pharmacy and a PhD in Pharmaceutical Sciences. Originally from a region endemic for Chagas disease, Debora has valuable insight into parasitic infections such as Trypanosoma cruzi. Her research focuses on the design, characterization, and preclinical evaluation of nanocarriers to improve the delivery and efficacy of therapeutic compounds. Debora leads preclinical studies for Chagas disease and actively fosters interdisciplinary and international collaborations. She is also dedicated to mentoring students and junior researchers, contributing to the advancement of science through both innovation and education.

Fanfan Du is a research associate professor in the Scott lab where he specializes in developing novel polymeric platforms for  therapeutic applications. He completed his undergraduate and PhD degree in polymer chemistry at the University of Science and Technology of China. He has been a member of the Scott group for nearly a decade. 

He obtained his Ph.D. from Peking Union Medical College in Microbiology-pharmacy and M.S. from ShenYang Pharmaceutical University. Animal models of TD1M related of long-term complications, inflammation and immune-regulation diseases, and cancers are studied refine the application of nanoparticles more in therapeutic diagnostics applications, diseases presentments and targeted drug delivery system. He also had many years’ experience of by using different methods delivery CRISPR/Cas9 reagents to mice zygote to make knock-in/out or point mutation mice. He likes go to the gym to swim after work.

Hyeohn Kim obtained her Ph.D. in Material Science and Engineering from Seoul National University, and M.S. and B.S. in Material Science and Engineering from Yonsei University, Korea. She is currently working on the development of a novel hydrogel platform for long-term drug and gene delivery. Her research interests include the design of bionanomaterials for targeted delivery and biosensing.

Gan Lin is a postdoctoral researcher in the Scott lab where he applies immunotherapy-loaded sonosensitized bicontinuous nanospheres and ultrasound to treat solid tumors. He obtained his PhD in Nanostructured Materials from the University of Melbourne. He joined the Scott Lab from a postdoctoral fellowship at the University of Chicago.

Sultan earned a BS in Biomedical Engineering from Purdue University and an MS in Biomedical Engineering from Northwestern University. His research centers on the development of a nanoparticle-based tuberculosis vaccine that leverages Mtb lipid–restricted T cells to enhance immune targeting.

Natalie earned her B.S. in biomedical engineering and a minor in mechanical engineering and then worked for 2 years in early-phase drug discovery. Her work centers on applying tolerogenic nanoparticles towards delaying the onset of type 1 diabetes.

El Hadji is a Bachelor of Science graduate in Biomedical Engineering at Brown University. He is  interested in research about drug delivery, immunoengineering and nanotechnology.

Natalia Mendonca earned her BS in Biomedical Engineering from The Ohio State University. She is an NSF GRFP recipient. Her work centers on targeted gene delivery for the treatment of glaucoma. She is co-advised by Mark Johnson.

Sofi has previously focused on nanoencapsulation of hydrophobic compounds and the mathematical modeling of particle size using ultrasound processing at Tecnológico de Monterrey, Mexico. Her current research interests are in the areas of targeted drug delivery and regenerative medicine for glaucoma. She is co-advised by Mark Johnson.

Bobby earned a BS in Biology from Illinois Wesleyan University and an MS in biotechnology from Northwestern University. Co-advised by Dr. Scott and Dr. Lisa Volpatti, he has been developing novel polymers for systemic delivery of various nucleic acids.

Austeja earned her BS and MS from IIT before joining the Scott lab. She was awarded the NSF GRFP. She is currently focused on drug delivery for Chagas disease.